GlassScriptPhysician profile
Miranda Mae Pickens
NPI 1093488322
$3,141.27
in general payments reported to CMS, 2019-2025
39 companies · $1,024 in 2025
The $1,024 reported for 2025 was more than what 87% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $158 · 2022: $528 · 2023: $624 · 2024: $808 · 2025: $1,024.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,456.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,455.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $669.75 | 2022-2025 | |
| Amgen INC. | $354.50 | 2022-2025 | Otezla, Repatha, Repatha |
| Axsome Therapeutics, INC. | $243.35 | 2023-2025 | Auvelity, Symbravo |
| Pfizer INC. | $197.62 | 2022-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $170.72 | 2021-2025 | |
| Lilly USA, LLC | $153.83 | 2023-2025 | Mounjaro, Trulicity, Zepbound |
| Novo Nordisk INC | $120.97 | 2021-2025 | Wegovy, Ozempic, Rybelsus |
| Dexcom, INC. | $113.02 | 2022-2024 | Dexcom G6 Transmitter |
| Boehringer Ingelheim Pharmaceuticals, INC. | $109.68 | 2021-2025 | Jardiance, Synjardy |
| Astrazeneca Pharmaceuticals LP | $106.04 | 2021-2025 | Breztri |
| Phathom Pharmaceuticals, INC. | $94.56 | 2024-2025 | Voquezna |
| Exact Sciences Corporation | $89.99 | 2023-2025 | The Cologuard Plus Collection Kit, Cologuard Collection Kit |
| Organon LLC | $65.09 | 2023-2025 | Nexplanon |
| Novartis Pharmaceuticals Corporation | $63.77 | 2022-2024 | |
| Otsuka America Pharmaceutical, INC. | $63.33 | 2023-2025 | Rexulti |
Show all 39 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Miranda Pickens listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.